Recce Pharmaceuticals gains ethics approval for Phase 3 clinical trial in Indonesia

Recce Pharmaceuticals reaches midpoint in Phase II Trial for Topical Gel R327GПодробнее

Phase 3 Clinical Trials, Drug will available in Market after Phase 3Подробнее

Recce Pharmaceuticals highlights positive safety data from RECCE® 327 IV trialПодробнее

Recce Pharmaceuticals ready for Phase 3 trial for R327G in IndonesiaПодробнее

Recce Starts Phase 2 R327 Gel trial for bacterial skin infectionsПодробнее

Ausbiz Interview - Recce Pharmaceuticals (RCE)Подробнее

Recce Pharmaceuticals – equity propositionПодробнее

Recce Pharmaceuticals lands ethics approval for expanded UTI studiesПодробнее

The European Clinical Trial Directive for Medicinal ProductsПодробнее

Clinical SAS: What is a clinical trial protocol?Подробнее

Raph Hamers: Developing collaborative clinical trials in IndonesiaПодробнее

Patient Participation in Clinical Trials - ReneoПодробнее

Phase III Clinical Trials: Is It Better Than What’s Already Available?Подробнее

REPO-TRIAL: Prof. Dr. med. Daniel Sedding on the regulatory hurdles for clinicial trials in GermanyПодробнее

Ethics in Clinical TrialsПодробнее

Phase 3 Trials...the step before FDA approvalПодробнее

ERNICA Research Collaboration - Clinical TrialsПодробнее